23. Segment Information
Audited information- Index
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
Clariant has grouped its activities into four Business Areas (reportable segments): Care Chemicals (BU ICS), Catalysis (BU Catalysts), Natural Resources (BU Oil & Mining Services, BU Functional Minerals) and Plastics & Coatings (BU Additives, BU Master-batches, BU Pigments).
Intersegment transactions are entered into under the normal circumstances and terms and conditions that would also be available to unrelated third parties.
Segment assets consist of property, plant and equipment, goodwill, intangible assets, inventories, receivables and investments in associates. They exclude deferred tax assets, financial assets and operating cash. Segment liabilities comprise trade payables. They exclude items such as tax liabilities, provisions, pension liabilities and corporate borrowings. Capital expenditure comprises additions to property, plant and equipment and intangibles.
Care Chemicals |
Catalysis |
Natural Resources |
Plastics & Coatings |
Corporate |
Total Group |
|||||||||||||||||||||||||
|
2018 |
2017 |
2018 |
2017 |
2018 |
2017 |
2018 |
2017 |
2018 |
2017 |
2018 |
2017 |
||||||||||||||||||
|
||||||||||||||||||||||||||||||
Segment sales |
1 681 |
1 589 |
862 |
767 |
1 403 |
1 364 |
2 736 |
2 709 |
— |
— |
6 682 |
6 429 |
||||||||||||||||||
Sales to other segments |
–16 |
–14 |
–1 |
— |
–9 |
–7 |
–33 |
–31 |
— |
— |
–59 |
–52 |
||||||||||||||||||
Total sales |
1 665 |
1 575 |
861 |
767 |
1 394 |
1 357 |
2 703 |
2 678 |
— |
— |
6 623 |
6 377 |
||||||||||||||||||
Operating expenses |
–1 414 |
–1 375 |
–750 |
–639 |
–1 298 |
–1 223 |
–2 375 |
–2 381 |
–240 |
–263 |
–6 077 |
–5 881 |
||||||||||||||||||
Thereof: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Income from associates and joint ventures3 |
29 |
10 |
17 |
11 |
16 |
5 |
54 |
30 |
14 |
47 |
130 |
103 |
||||||||||||||||||
Gain/loss from disposals not qualifying as discontinued operations |
— |
— |
— |
— |
— |
— |
— |
1 |
–54 |
2 |
–54 |
3 |
||||||||||||||||||
Restructuring, impairment and transaction-related costs |
–2 |
–30 |
–14 |
–7 |
–22 |
–14 |
–4 |
–14 |
–51 |
–115 |
–93 |
–180 |
||||||||||||||||||
Operating income |
251 |
200 |
111 |
128 |
96 |
134 |
328 |
297 |
–240 |
–263 |
546 |
496 |
||||||||||||||||||
Net financial expenses and taxes |
|
|
|
|
|
|
|
|
|
|
–190 |
–194 |
||||||||||||||||||
Net income |
|
|
|
|
|
|
|
|
|
|
356 |
302 |
||||||||||||||||||
Segment assets |
1 158 |
1 160 |
1 724 |
1 780 |
1 228 |
1 298 |
1 746 |
1 798 |
|
|
5 856 |
6 036 |
||||||||||||||||||
Segment liabilities |
–252 |
–244 |
–159 |
–90 |
–159 |
–150 |
–282 |
–273 |
|
|
–852 |
–757 |
||||||||||||||||||
Net operating assets |
906 |
916 |
1 565 |
1 690 |
1 069 |
1 148 |
1 464 |
1 525 |
— |
— |
5 004 |
5 279 |
||||||||||||||||||
Net assets held for sale |
7 |
10 |
5 |
5 |
— |
4 |
2 |
2 |
1 |
1 |
15 |
22 |
||||||||||||||||||
Corporate assets without cash |
|
|
|
|
|
|
|
|
1 244 |
1 416 |
1 244 |
1 416 |
||||||||||||||||||
Corporate liabilities without financial liabilities |
|
|
|
|
|
|
|
|
–1 919 |
–2 239 |
–1 919 |
–2 239 |
||||||||||||||||||
Net debt see note 18 |
|
|
|
|
|
|
|
|
–1 374 |
–1 539 |
–1 374 |
–1 539 |
||||||||||||||||||
Total net assets |
913 |
926 |
1 570 |
1 695 |
1 069 |
1 152 |
1 466 |
1 527 |
–2 048 |
–2 361 |
2 970 |
2 939 |
||||||||||||||||||
Thereof: |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Investments in PPE and intangibles for the period |
61 |
61 |
56 |
36 |
42 |
49 |
75 |
86 |
23 |
47 |
257 |
279 |
||||||||||||||||||
Investments in associates and joint ventures at the end of the period |
87 |
64 |
118 |
121 |
9 |
9 |
151 |
154 |
3 |
160 |
368 |
508 |
||||||||||||||||||
Reconciliation of key figures |
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
Operating income |
251 |
200 |
111 |
128 |
96 |
134 |
328 |
297 |
–240 |
–263 |
546 |
496 |
||||||||||||||||||
Add: systematic depreciation of PPE |
56 |
54 |
55 |
41 |
38 |
36 |
66 |
68 |
30 |
32 |
245 |
231 |
||||||||||||||||||
Add: impairment |
— |
— |
— |
1 |
— |
1 |
— |
12 |
— |
2 |
— |
16 |
||||||||||||||||||
Add: amortization of intangible assets |
7 |
6 |
19 |
22 |
23 |
23 |
14 |
10 |
17 |
9 |
80 |
70 |
||||||||||||||||||
EBITDA1 |
314 |
260 |
185 |
192 |
157 |
194 |
408 |
387 |
–193 |
–220 |
871 |
813 |
||||||||||||||||||
Add: restructuring, impairment and transaction-related costs |
2 |
30 |
14 |
7 |
22 |
14 |
4 |
14 |
51 |
115 |
93 |
180 |
||||||||||||||||||
Less: impairment |
— |
— |
— |
–1 |
— |
–1 |
— |
–12 |
— |
–2 |
— |
–16 |
||||||||||||||||||
Less: gain/loss from disposals not qualifying as discontinued operations2 |
— |
— |
— |
— |
— |
— |
— |
–1 |
54 |
–2 |
54 |
–3 |
||||||||||||||||||
Adjusted EBITDA |
316 |
290 |
199 |
198 |
179 |
207 |
412 |
388 |
–88 |
–109 |
1 018 |
974 |
||||||||||||||||||
Operating income |
251 |
200 |
111 |
128 |
96 |
134 |
328 |
297 |
–240 |
–263 |
546 |
496 |
||||||||||||||||||
Add: restructuring, impairment and transaction-related costs |
2 |
30 |
14 |
7 |
22 |
14 |
4 |
14 |
51 |
115 |
93 |
180 |
||||||||||||||||||
Less: gain/loss from disposals not qualifying as discontinued operations |
— |
— |
— |
— |
— |
— |
— |
–1 |
54 |
–2 |
54 |
–3 |
||||||||||||||||||
Adjusted operating income |
253 |
230 |
125 |
135 |
118 |
148 |
332 |
310 |
–135 |
–150 |
693 |
673 |
in CHF m |
31.12.2018 |
31.12.2017 |
||
Segment assets |
5 856 |
6 036 |
||
Segment assets reported as assets held for sale |
14 |
21 |
||
Corporate assets reported as assets held for sale |
1 |
1 |
||
Corporate assets without cash |
1 244 |
1 416 |
||
Cash |
833 |
701 |
||
Short-term deposits |
26 |
47 |
||
Financial instruments with positive fair values |
7 |
7 |
||
Total Assets |
7 981 |
8 229 |
Sales1 |
Non-current assets2 |
|||||||||||
|
2018 |
2017 |
31.12.2018 |
31.12.2017 |
||||||||
|
||||||||||||
EMEA |
2 803 |
2 674 |
2 275 |
2 438 |
||||||||
of which Germany |
778 |
757 |
1 391 |
1 458 |
||||||||
of which Switzerland |
39 |
34 |
490 |
585 |
||||||||
of which MEA |
481 |
480 |
55 |
62 |
||||||||
North America |
1 295 |
1 241 |
1 205 |
1 234 |
||||||||
of which USA |
1 206 |
1 143 |
1 187 |
1 213 |
||||||||
Latin America |
775 |
830 |
226 |
248 |
||||||||
of which Brazil |
321 |
355 |
124 |
146 |
||||||||
Asia/Pacific |
1 750 |
1 632 |
636 |
663 |
||||||||
of which China |
624 |
534 |
177 |
182 |
||||||||
of which India |
237 |
209 |
200 |
217 |
||||||||
Total |
6 623 |
6 377 |
4 342 |
4 583 |
All of the Group’s segments generate their revenues to the largest extent from the sale of products. These come in such a great variety that a meaningful grouping below the segment information is not possible.
Revenue from services recognized in 2018 amounted to CHF 89 million and mostly were incurred in Business Area Natural Resources.
For a description of the Business Units see note 1.24.
In 2013 Clariant adjusted its reporting segments and grouped its businesses with similar end-user markets and growth drivers into four distinct Business Areas: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. View entire glossary